Title: Comment on: A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis
Authors: Huan Xu1, Hongbo Chen1
Affiliations: 1 Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
Correspondence: Hongbo Chen, Address: Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, China, Telephone: +86-13006114930, Email: hbchen@hust.edu.cn.
Word Count for Main Text: 505
Running Heads: Ruxolitinib therapy for HLH in children
Keywords: Ruxolitinib, HLH, therapy